Ana Tomás
Impact in
-
- Antibiotic Use and Resistance
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Pharmacology 13
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Antibiotic Use and Resistance 13
- Co-authors
- Milica Paut Kusturica (26 shared papers)Ana Sabo (22 shared papers)Olga Horvat (27 shared papers)Z. Tomić (21 shared papers)Nebojša Stilinović (17 shared papers)Aleksandar Rašković (9 shared papers)Suzanne Erb (1 shared paper)Peter McGuffin (1 shared paper)
- Journals
- Antibiotics (3 papers)Clinical Therapeutics (3 papers)Saudi Pharmaceutical Journal (2 papers)International Journal of Environmental Research and Public Health (2 papers)International Journal of Clinical Pharmacy (2 papers)
- Partner nations
- SerbiaSwitzerlandPoland
In The Last Decade
Ana Tomás
51 papers receiving 733 citations
Peers
Comparison fields: 5 of 117
- Applied Microbiology and Biotechnology 146
- Geriatrics and Gerontology 49
- Biological Psychiatry 31
- Behavioral Neuroscience 34
- Molecular Medicine 42
Countries citing papers authored by Ana Tomás
This map shows the geographic impact of Ana Tomás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Tomás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Tomás more than expected).
Fields of papers citing papers by Ana Tomás
This network shows the impact of papers produced by Ana Tomás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Tomás. The network helps show where Ana Tomás may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Tomás, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 115 | |
| 2 | 2016 | 101 | |
| 3 | 2006 | 49 | |
| 4 | 2020 | 43 | |
| 5 | 2017 | 40 | |
| 6 | 2019 | 40 | |
| 7 | 2016 | 34 | |
| 8 | 2017 | 30 | |
| 9 | 2020 | 29 | |
| 10 | 2021 | 24 | |
| 11 | 2021 | 19 | |
| 12 | 2018 | 18 | |
| 13 | 2020 | 16 | |
| 14 | 2022 | 15 | |
| 15 | 2023 | 14 | |
| 16 | 2015 | 14 | |
| 17 | 2023 | 12 | |
| 18 | 2020 | 11 | |
| 19 | 2017 | 11 | |
| 20 | 2018 | 11 |
About Ana Tomás
Ana Tomás is a scholar working on Pharmacology, Applied Microbiology and Biotechnology, Molecular Medicine, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 55 papers that have together received 751 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (13 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Blood Pressure and Hypertension Studies (5 papers), Pneumonia and Respiratory Infections (4 papers), Pharmaceutical Economics and Policy (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers) and Forensic Toxicology and Drug Analysis (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (146 citations), Geriatrics and Gerontology (49 citations), Biological Psychiatry (31 citations), Behavioral Neuroscience (34 citations) and Molecular Medicine (42 citations). Ana Tomás has collaborated with scholars based in Serbia, Switzerland and Poland. Frequent co-authors include Milica Paut Kusturica, Ana Sabo, Olga Horvat, Z. Tomić, Nebojša Stilinović, Aleksandar Rašković, Suzanne Erb, Peter McGuffin, Marcella Rietschel and Rudolf Uher. Their work appears in journals such as Antibiotics, Clinical Therapeutics, Saudi Pharmaceutical Journal, International Journal of Environmental Research and Public Health and International Journal of Clinical Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.